QuantuMDx launches new PCR respiratory panel | Health Tech World
QuantuMDx Scales Up to Mass Manufacture Q-POC | Clinical Lab Products
The QuantuMDx Q-POC™ SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a nov
transmitted infections (STIs). QuantuMDx is developing to be achieved.
Menarini Diagnostics > Home > Professional Diagnostics > COVID-19 > Viral RNA Detection > Q-POC > Technical Data
CDP completes pilot manufacture of Point of Care diagnostic readers for rapid COVID-19 testing – Cambridge Design Partnership
QuantuMDx (@QuantuMDx) / X
Sansure and QuantuMDx, to jointly build intelligent and diversified overall solution for POCT
Q-POC | DYNEX
CDP completes pilot manufacture of Point of Care diagnostic readers for rapid COVID-19 testing – Cambridge Design Partnership
QuantuMDx | Newcastle upon Tyne
Products & Solutions - QuantuMDx
QuantuMDx launches Q-POC rapid PCR point of care diagnostic system in the UK
QuantuMDx launch 30 minute rapid COVID-19 PCR test - Med-Tech Innovation
Assessment of QuantuMDx Q-POC Assay for Rapid Detection of SARS-CoV-2 Using Middle Turbinate Swabs | Microbiology Spectrum
The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology | Scientific Reports
Jonathan O'Halloran on LinkedIn: NEW! Q-POC™ SARS-CoV-2 Flu A/B RSV Assay
Q-POC™ SARS-CoV-2
QuantuMDx introduces PCR diagnostic system for Covid-19 detection
Respiratory Solution
This smartphone-sized device can diagnose cancer in 20 minutes | Guardian sustainable business | The Guardian
QuantuMDx Launches MolDx Indiegogo Campaign
